Selected Publications

 “Selected Publications” in 2016

Ritter C, Fan K, Paulson KG, Nghiem P, Schrama D, Becker JC. Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma. Sci Rep. 2016; 6:21678; doi: 10.1038/srep21678.

Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, Johannesen HH, Becker JC, Pedersen KS, Dethlefsen C, Nielsen J, Gehl J, Pedersen BK, Thor Straten P, Hojman P. Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Cell Metab.2016;23(3):554-62. doi: 10.1016/j.cmet.2016.01.011.

Roesch A, Paschen A, Landsberg J, Helfrich I, Becker JC, Schadendorf D. Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma. Eur J Cancer. 2016; 59:109-12; doi: 10.1016/j.ejca.2016.02.023.

Zhao F, Sucker A, Horn S, Heeke C, Bielefeld N, Schrörs B, Bicker A, Lindemann, M, Roesch A, Gaudernack G, Stiller M, Becker JC, Lennerz V, Wölfel T, Schadendorf D, Griewank K, Paschen A. Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency. Cancer Res. 2016; PubMed PMID: 27261508.

Gambichler T, Mohtezebsade S, Wieland U, Silling S, Höh, AK, Dreißigacker M, Schaller J, Schulze HJ, Oellig  F, Kreuter A, Stockfleth E, Stücker M, Bechara FG, Becker JC. Prognostic relevance of high atonal homolog‐1 expression in Merkel cell carcinoma. J Cancer Res Clin Oncol. 2016; doi: 10.1007/s00432-016-2257-6